Atypical clinical presentation of Churg-Strauss syndrome with rapidly progressive glomerulonephritis: case report.

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

• Association of idiopathic retroperitoneal fibrosis, rapidly progressive glomerulonephritis and antiproteinase 3 antineutrophil cytoplasmic antibodies (anti PR3-ANCA).

  Authors: P Mart Iacute Nez-Odriozola, A Guti Eacute Rrez-Mac Iacute As, I Moina Eguren, J Arrieta Lezama

  Clinical nephrology. Volume 70(September):251-254.

• 'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.

  Authors: G Friedman, H Granot, Y Koplovic, M Friedlander

  Postgraduate medical journal. 57(663):54-6.

• Treatment of nephrotic syndrome associated with idiopathic rapidly progressive glomerulonephritis and cyclosporin A.

  Authors: F Maduell, A Sánchez-Alcaraz, F Sigüenza, A Caridad, G Sangrador

  Journal of clinical pharmacy and therapeutics. 18(1):59-62.

• Churg-Strauss syndrome presenting with diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis.

  Authors: Keishi Sugino, Naoshi Kikuchi, Yoko Muramatsu, Go Sano, Emiko Kusano, Kazutoshi Isobe, Susumu Sakamoto, Yujiro Takai, Chikako Hasegawa, Kazutoshi Shibuya, Kazuhito Hatanaka, Toshimasa Uekusa, Sakae Homma

  Internal medicine (Tokyo, Japan). 48(20):1807-11.

• Rapidly progressive glomerulonephritis complicating primary AL amyloidosis and multiple myeloma.

  Authors: Amy Crosthwaite, Alison Skene, Peter Mount

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25(8):2786-9.

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.